CHAMPIONS ONCOLOGY, INC. (CSBR) Gross margin 2020–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) gross margin by fiscal year — reported gross profit divided by reported revenue.
48.0%FY2026 · since FY2020: 47.1% → 48.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 48.0% | -2.1 pp |
| FY2025 | 50.1% | +8.8 pp |
| FY2024 | 41.4% | -3.8 pp |
| FY2023 | 45.2% | -6.7 pp |
| FY2022 | 51.9% | +4.1 pp |
| FY2021 | 47.7% | +0.7 pp |
| FY2020 | 47.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice